Skip to the ledger

GrantClerk

NSF award 2537925 · Phase, INC.

STTR Phase I: Redefining How PDMS Microfluidics Are Made Through Advanced 3D Printing to Facilitate Complex Biological Mechanism Studies

Final report due

28 September 2027

in 345 days · The award ends on 31 May 2027.

GrantClerk is a private service. We are not NSF or any government agency.

Dates this award owes

NSF emails you about this too.

  • Decide about an extension31 Jan 2027in 105 days

    award ending 2027-05-31 · Research.gov

  • Extension request16 Apr 2027in 180 days

    award ending 2027-05-31 · Research.gov

  • No-cost extension notice21 May 2027in 215 days

    award ending 2027-05-31 · Research.gov

  • Final report due28 Sep 2027in 345 days

    award ending 2027-05-31 · Research.gov

  • Project outcomes report due28 Sep 2027in 345 days

    award ending 2027-05-31 · Research.gov

  • Award is closed out28 Sep 2027in 345 days

    award ending 2027-05-31 · Research.gov

Annual report dates come from the budget period on your award notice. That date is not public, so it is not shown here.

How we got this date

  1. NSF lists this award's end date as 31 May 2027.
  2. NSF rules say the final report is due no later than 120 days after that.
  3. So the final report is due by 28 September 2027.

Read the rule on Research.gov

Get a note before each report date

Add this award to your desk. We email you before each date and keep the dates in one place.

Renews each year until you cancel. Cancel any time from your account.

Already a member? Sign in

Award card

Award number
2537925
Period of support
1 Jun 2026 – 31 May 2027
Amount
$304,761
Awardee
Phase, INC., Cornelius, NC
Program
STTR Phase I
Directorate
TIP

Abstract

The broader/commercial impact of this Small Business Technology Transfer (STTR) Phase I project is to enable reliable, high-resolution 3D printing of microfluidic devices using a widely trusted silicone material that is foundational to biomedical research. Microfluidic systems, often called “labs on a chip,” are essential tools for studying diseases, testing new drugs, and developing advanced models that replicate…

Is this right?

We copy this from the public NSF award record. Your award notice and NSF always win. If a date looks wrong, check Research.gov.